𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The risk of drug-eluting stent thrombosis with noncardiac surgery

✍ Scribed by Emmanouil S. Brilakis; Subhash Banerjee; Peter B. Berger

Publisher
Springer
Year
2007
Tongue
English
Weight
1003 KB
Volume
9
Category
Article
ISSN
1523-3782

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Late thrombosis of sirolimus-eluting ste
Late thrombosis of sirolimus-eluting stents following noncardiac surgery
✍ Mithal Nasser; Michael Kapeliovich; Walter Markiewicz πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 2 views

We describe two patients with in-stent thrombosis occurring 4 and 21 months after implantation of sirolimus-eluting stents. Both cases occurred following noncardiac surgery. In both cases, aspirin had been stopped prior to surgery. Both patient sustained a severe myocardial infarction; one died. The

Discontinuation of antiplatelet therapy
Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: A retrospective cohort study
✍ Daniel J. Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L. Bhatt; Kath πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND Drug‐eluting coronary stents (DESs) pose a challenge in the perioperative period. Sirolimus and paclitaxel may inhibit reendothelialization of the traumatized vessel, making it vulnerable to platelet‐mediated thrombosis. Given the anecdotal evidence and case series sugges